Literature DB >> 18615106

Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia.

F A Fierro, S Brenner, U Oelschlaegel, A Jacobi, H Knoth, G Ehninger, T Illmer, M Bornhäuser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18615106     DOI： 10.1038/leu.2008.182

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  17 in total

Review 1.  The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Authors:  Edward Allan R Sison; Patrick Brown
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

2.  Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML.

Authors:  Wei Du; Xu-E Li; Jared Sipple; Qishen Pang
Journal:  Blood       Date:  2011-02-17       Impact factor: 22.113

3.  Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

Authors:  Zhihong Zeng; Yue Xi Shi; Ismael J Samudio; Rui-Yu Wang; Xiaoyang Ling; Olga Frolova; Mark Levis; Joshua B Rubin; Robert R Negrin; Elihu H Estey; Sergej Konoplev; Michael Andreeff; Marina Konopleva
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

4.  CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.

Authors:  Ye Chen; Rodrigo Jacamo; Marina Konopleva; Ramiro Garzon; Carlo Croce; Michael Andreeff
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

Review 5.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

Review 6.  The good and the bad of chemokines/chemokine receptors in melanoma.

Authors:  Ann Richmond; Jinming Yang; Yingjun Su
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-14       Impact factor: 4.693

Review 7.  Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.

Authors:  Keith J August; Aru Narendran; Kathleen A Neville
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

8.  Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines.

Authors:  Ryan D Nipp; Arati V Rao
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-06-19       Impact factor: 6.053

9.  Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts.

Authors:  Angela Jacobi; Sebastian Thieme; Romy Lehmann; Fernando Ugarte; Harry L Malech; Sina Koch; Christian Thiede; Katrin Müller; Martin Bornhäuser; Martin Ryser; Sebastian Brenner
Journal:  Exp Hematol       Date:  2009-12-24       Impact factor: 3.084

10.  Studying leukemia stem cell properties and vulnerabilities with human iPSCs.

Authors:  Nikolaos Spyrou; Eirini P Papapetrou
Journal:  Stem Cell Res       Date:  2020-12-10       Impact factor: 1.587
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.